Prostate cancer cases in the United States have climbed roughly 3% per year between 2014 and 2022, with the steepest increases coming in advanced-stage diagnoses. The American Cancer Society estimates there will be 333,830 new cases and 36,320 deaths from the disease in 2026 alone.
According to Healthline, which reviewed data from the American Cancer Society, the rise in overall diagnoses is largely tied to more men getting screened. But many are still not being screened early enough, which is driving the increase in cases caught at later, harder-to-treat stages.
One in 8 men will be diagnosed with prostate cancer in their lifetime. Black men face a nearly 70% higher incidence rate than white men. Despite those numbers, more than 3.5 million men with prostate cancer are alive today, a figure that reflects how treatable the disease can be when caught early.
When prostate cancer is found before it has spread to distant parts of the body, the 5-year relative survival rate exceeds 99%. That number drops significantly for late-stage diagnoses, which is why medical professionals are pushing for earlier and more consistent screening.
S. Adam Ramin, MD, a board-certified urologist and medical director of Urology Cancer Specialists in Los Angeles, told Healthline that "The benefits of detecting prostate cancer at an earlier, localized stage are profound." He said early detection opens up a broader range of treatment options, including active surveillance, surgery, and various forms of radiation therapy, some of which are minimally invasive and carry lower risk of significant side effects.
Ramin noted that localized prostate cancer, meaning cancer that has not spread beyond the prostate gland, carries a nearly 100% 5-year survival rate. He added that catching the cancer while it is still small and confined often allows for less aggressive treatment, which can mean better quality of life after treatment, with less impact on urinary function and sexual health.
Age is among the primary risk factors. Six in 10 prostate cancer cases are found in men over 50. Family history and race also factor into individual risk levels. Because risk varies from person to person, medical professionals say the decision to screen should involve a conversation between the patient and their doctor about personal risk factors.
September is Prostate Cancer Awareness Month. The American Cancer Society is using the occasion to encourage men to speak with their healthcare providers about whether screening is appropriate for them, particularly those in higher-risk groups who may benefit most from earlier detection.
